Advan'ce'd
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer (NCT07361991) | The First Affiliated Hospital of Zhengzhou University | 2026-03-01 |
Track Advan'ce'd automatically
Every clearance here is in the API, with alerts when new ones post.